The effect of digoxin on mortality and morbidity in patients with heart failure.
By G. Perry, E. Brown, R. Thornton, T. Shiva, J. Hubbard, K. R. Reddy, J. Doherty, F. Cardello, A. Fast, M. Radford and 388 more. 1997
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Rohith Krishna
- Jue Wang
- Ivan V. Anishchenko
- Minkyung Baek
- Woody Ahern
- Ryan McHugh
- Pascal Sturmfels
- Indrek Kalvet
Citations in the corpus
- Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom (2023, background): “Digoxigenin (DIG) is the aglycone of digoxin, a small molecule used to treat heart diseases with a narrow therapeutic window ( 52 ), and digoxigenin-binding proteins could help reduce toxicity ( 53 ).”